Picture of Bio Vitos Pharma AB logo

BIOVIT Bio Vitos Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Hemcheck Q4 Loss After Financial Items Narrows To SEK 2.9 Million

Feb 14 (Reuters) - Hemcheck Sweden AB  HEMC.ST :
    * Q4 LOSS AFTER FINANCIAL ITEMS SEK 2.9 MILLION VERSUS LOSS
SEK
3.5 MILLION YEAR AGO

Source text for Eikon:  ID:nWkr9hrf6r 
Further company coverage:  HEMC.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Bio Vitos Pharma AB

See all news